Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
about
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacementProlonged thromboprophylaxis with Low Molecular Weight heparin for abdominal or pelvic surgeryPrevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesVTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesLow molecular weight heparin-induced skin necrosis-a systematic review.Choosing the appropriate antithrombotic agent for the prevention and treatment of VTE: a case-based approach.Low-molecular-weight heparin prophylaxis of deep vein thrombosis for older patients with restricted mobility: propensity analyses of data from two multicentre, cross-sectional studies.Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?Pathways for venous thromboembolic prophylaxis in medical and surgical patients.Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery.Symptomatic venous thromboembolism and mortality in orthopaedic surgery - an observational study of 45 968 consecutive proceduresExtended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol.From Trousseau to targeted therapy: new insights and innovations in thrombosis and cancer.Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international surveyPerioperative care of the patient with hip fracture.The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.Evidence for extended prophylaxis in the setting of orthopedic surgery.Assessment of the risk and the prophylaxis of venous thromboembolism in surgical patients.Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty.Ximelagatran in orthopaedic surgery.Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic testsThe post-thrombotic syndrome: the forgotten morbidity of deep venous thrombosis.Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis.Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.Extended duration of thromboprophylaxis in acutely ill medical patients: optimizing therapy?Postdischarge thromboprophylaxis and mortality risk after hip-or knee-replacement surgery.Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.Thromboprophylaxis in elderly patients undergoing major orthopaedic surgery.The Prophylaxis of Venous Thromboembolism.Primary prevention of venous thromboembolism in elderly medical patientsAn evaluation of practice pattern for venous thromboembolism prevention in Lebanese hospitals.Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.Economic and practical aspects of thromboprophylaxis with unfractionated and low-molecular-weight heparins in hospitalized medical patients.Physician alerts to prevent venous thromboembolism.Intermittent Pneumatic Compression for the Prevention of Venous Thromboembolism after Total Hip Arthroplasty.Need to improve thromboprophylaxis across the continuum of care for surgical patients.Review article: thromboprophylaxis after total hip replacement.The eighth American college of chest physicians guidelines on venous thromboembolism prevention: implications for hospital prophylaxis strategies.Extended therapy for primary and secondary prevention of venous thromboembolism.
P2860
Q24235993-C8119B20-2BD7-4C16-979B-ABFC78D3A87BQ24241736-0E7B56AD-5744-44D4-A7DA-4E66CB74C3A8Q24632872-AF46BEE4-0248-4E80-81C3-2FD41AB6C47FQ24632982-8EDF11E2-B6AE-4118-BFB2-DC6CBC984AE9Q33363909-91D146B9-E40C-4642-8D7C-FC1443DD1FFBQ33372266-A6B2DC57-A227-44A4-9229-F869D5A7D61EQ33428745-064C224A-EE8D-47F2-A73A-952027BE6689Q33824047-70C0D0B1-E441-4CC1-B12B-FED4B5C54342Q34264223-2DB302DE-6414-44A4-95F1-F2FCF4881655Q34561015-4786CD82-73FD-49FA-86FC-F1A241703446Q34756347-A389F6D6-6990-4B75-B808-507D0185A424Q34959822-441D09D7-119E-43F2-A6D4-9FD3A6723865Q35181616-F9ACB99D-3398-4A19-B2D2-2A76AEEFF888Q35588756-5ACDFC67-1E29-4035-8BA0-A29D280D3DB4Q35677708-ED2933CA-65A0-4717-A638-478681CA81E7Q35810463-4FF40034-F1D8-4720-A5B6-CD5998BE24F1Q35866089-C5D8C3B9-BB83-448C-BD8A-A3C4A3A5B5F7Q36030498-B20FEF12-A1BE-4C7B-9975-E61B6A45F634Q36068886-EC523E3D-BDC6-4817-B4AD-CDECF92670A1Q36090077-2CBE5D6E-5D3A-42F0-BDAA-197D0FDF27E1Q36160668-9D2B6E84-7D23-49DF-B450-DBF7D3C0D386Q36259760-84FB46D0-CCAA-44D5-8BA6-F30B6D750D6CQ36395270-3232162C-BC4C-400F-8BED-F36A26255AF6Q36503092-C96D73B5-70C4-4F56-A09E-8837259BE1E7Q36564967-C97E7DA7-505D-4B12-B33C-8339E8EE0A3FQ36632271-1CC8394F-6001-4426-B938-8ABE4D55C0F5Q36676398-215A30D1-24EE-4EAE-90CE-6AB4622039F7Q36935821-7D6FD5F9-A1B1-4789-9EBE-430701297314Q37200820-5B9BC6C0-28C0-4D67-AAD5-B021A6272AEFQ37233818-C5B0EDF6-385D-4D50-A422-C899D36FA3B9Q37316796-36363E38-1A4D-49B4-AF12-A91377DD4CC0Q37358830-27D3CDBE-6E49-46C9-A595-19C1C8E7E172Q37472172-E53EA9C5-DAE0-4BEC-AC7B-074DCBB9D9CEQ37516892-90E12A59-7FED-4BF2-803A-9A604DF4C542Q37627200-E3DB8070-0A9F-41EF-8B8C-CB7B90579F17Q37677489-80B2AF01-BD0F-4588-A4CD-34F88C3623CDQ37730609-2ED250A0-C805-4315-A6C6-90AC0A7571F2Q37739087-6E54DA57-1C2A-4C8F-845A-C92284158648Q37777972-00A13F1E-2DE2-49D7-B77D-23E287A00966Q37867288-B2DC3732-91AC-45D7-A29E-3ED566B887A8
P2860
Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@ast
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@en
type
label
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@ast
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@en
prefLabel
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@ast
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@en
P2093
P31
P1476
Extended out-of-hospital low-m ...... roplasty: a systematic review.
@en
P2093
Bergqvist D
MacIsaac SM
P304
P356
10.7326/0003-4819-135-10-200111200-00006
P407
P577
2001-11-01T00:00:00Z